News Netarsudil Lowers IOP, but When Should It Be Given? by Medscape • 2019/01/02 • 0 Comments Findings from the ROCKET trials shed light on --and also raise questions about --this newly approved medication for glaucoma. Medscape Ophthalmology Full Story →